title: The hazards of intermediate endpoints.
authors.forename: Tomasz M
authors.initials: TM
authors.lastname: Beer
authors.forename: Christopher W
authors.initials: CW
authors.lastname: Ryan
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D002986:Clinical Trials as Topic / Q000379:methods*; D018572:Disease-Free Survival; D023381:Endpoint Determination; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy / Q000401:mortality*
chemical_list: D000970:Antineoplastic Agents